UCSF

Tagged: COVID-19

New fund supports faculty members struggling with pandemic-related career disruptions

The Faculty Resource Fund is offering two levels of awards to support faculty members affected by COVID-19 pandemic. The deadline to apply is March 9.

Cancer drug stops SARS-CoV-2 in the lab

“If you get a drug that targets a human protein, it would be incredibly hard for the virus to mutate away from being reliant on it,” said Nevan Krogan, the director of QBI.

How we know it’s safe to get the vaccine

UCSF experts address the safety of the new COVID-19 vaccines

Update from the Dean: Community during challenging times

The School continues its vital work in research, education, and patient care.

Jamming the gears of a deadly virus

Team efforts at the School and beyond produce two potential treatments for COVID-19.

QBI probes three lethal coronaviruses to find possible drug targets

“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.

Update from the Dean: Back to school

Dean Guglielmo provides updates on ongoing efforts with science, education, and patient care in the School.

Nanobody-based antiviral developed at UCSF effectively blocks SARS-CoV-2 in the lab

School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray.

How targeting a key SARS-CoV-2 enzyme could lead to an antiviral drug

The chemical fragments could bind to and disable an enzyme that helps the virus replicate.

SARS-CoV-2 may spur growth of molecular “railways” out of infected cells, School scientists show

UCSF-led collaboration uncovers new avenues for COVID-19 drug discovery

Pages